Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
EpiVax and Zoetis to Collaborate on Swine T cell Epitope Prediction Tool: CircoMatch™ 2023-01-10 21:00
Treadwell Therapeutics Announces Fast Track Designation Granted by the FDA to CFI-402257 for the Treatment of ER+/HER2- Breast Cancer 2023-01-10 21:00
Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase™ 2023 2023-01-10 20:30
Dizal Announces China CDE Acceptance of New Drug Application for Sunvozertinib for Platinum-Pretreated NSCLC Patients with EGFR Exon20ins Mutations 2023-01-10 17:03
FAPON to attend 41st Annual J.P. Morgan Healthcare Conference 2023-01-10 16:37
General Biologicals Corporation (GBC) and Chairman Lin Tsong-Chin Honored at Asia Pacific Enterprise Awards 2022 Taiwan 2023-01-10 09:54
Lydus Medical Announces FDA Clearance of Vesseal™, The Microvascular Anastomosis Aid Device for Small Arteries 2023-01-10 09:00
SK Biopharmaceuticals to Present Future Plan for Global Investors, Partners at 'SK Bio Night' 2023-01-10 07:00
SK Inc. hosts "SK Bio Night" in San Francisco to expand global partnerships 2023-01-10 07:00
Alterity Therapeutics Launches ATH434 Phase 2 Clinical Trial in the United States for the Treatment of Individuals with Multiple System Atrophy 2023-01-09 23:25
Shanton Screens First Subjects in Phase 2b Refractory/Tophaceous Gout Study with SAP-001 2023-01-09 22:00
Mars Petcare and the Broad Institute create open-access database of dog and cat genomes to advance preventive pet care 2023-01-09 21:15
SK bioscience's Zoster Vaccine Receives Biologics License Application Approval in Malaysia 2023-01-09 21:00
SoniVie Raises $60m in Round C Financing, and Appoints New Board Members 2023-01-09 20:00
Immorna Receives IND Clearance to Conduct a Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine 2023-01-09 20:00
Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update 2023-01-09 06:37
Jacobio Completes First Patient Dosage of Aurora A Inhibitor JAB-2485 in U.S 2023-01-08 14:17
Fosun Pharma and Henlius Entered into an Exclusive License Agreement for Serplulimab in the US 2023-01-07 17:29
Ocedurenone (KBP-5074) Featured at ASN Kidney Week: Ocedurenone is a Potential New Treatment Option for Patients with Uncontrolled or Resistant Hypertension and Advanced CKD 2023-01-06 21:00
Double-blind period completes! Primary endpoint analysis of phase 3 clinical trial to be conducted for China's first hormone replacement treatment targeting hypoparathyroidism 2023-01-06 18:00
1 132 133 134 135 136 453